IL1B and endometriosis: NLRP3/IL-1β contributed to the etiology of endometriosis, and NLRP3 suppressors (MCC950) possibly helped to reduce ovarian endometriosis as well as enhanced the functionality of ovaries affected by endometriosis (127).